SubscribeIn the News

Alfalight Receives 2015 Wisconsin Innovation Award

Friday, August 28th, 2015 | Technology

HealthMyne Announces FDA Clearance of Imaging Informatics Platform

Tuesday, August 25th, 2015 | Technology

FLUGEN CLOSES $12 MILLION SERIES A FINANCING

Tuesday, August 25th, 2015 | Healthcare

Cellectar Biosciences Introduces Phospholipid Ether-Drug Conjugate (PDC) Platform for Targeted Delivery of Chemotherapeutics

Tuesday, August 25th, 2015 | Healthcare

MADISON VACCINES ANNOUNCES PATIENT DOSING UNDERWAY IN CLINICAL TRIAL PAIRING ITS LEAD PROSTATE CANCER VACCINE, MVI-816, WITH PD1 INHIBITOR PEMBROLIZUMAB

Thursday, August 20th, 2015 | Healthcare

NEUWAVE MEDICAL, INC., RECEIVES FDA CLEARANCE FOR ABLATION CONFIRMATION SOFTWARE

Thursday, August 13th, 2015 | Healthcare

HEALTHMYNE, INC., AND UNIVERSITY OF WISCONSIN MOVE FORWARD WITH IMAGING INFORMATICS IMPLEMENTATION

Thursday, August 13th, 2015 | Technology

AERPIO THERAPEUTICS ANNOUNCES POSITIVE RESULTS OF A PHASE 2A STUDY OF AKB-9778 IN DIABETIC MACULAR EDEMA: THE TIME-2 TRIAL

Wednesday, July 15th, 2015 | Healthcare

ALFALIGHT COMPLETES DELIVERY OF 850 WEAPON-MOUNTED LASERS

Friday, July 10th, 2015 | Technology

A CHAT WITH CELECTAR’S NEW CEO

Friday, July 3rd, 2015 | Healthcare

INTEGRATED PEST PROGRAM HELPS SORGHUM GROWERS

Monday, June 29th, 2015 | Clean Tech

JUVENTAS THERAPEUTICS GRANTED FDA FAST TRACK DESIGNATION AND PHASE 2B PROTOCOL ALLOWANCE FOR NOVEL HEART FAILURE GENE THERAPY

Tuesday, June 16th, 2015 | Healthcare

CELLECTAR APPOINTS INDUSTRY VETERAN JIM CARUSO PRESIDENT AND CHIEF EXECUTIVE OFFICER

Tuesday, June 16th, 2015 | Healthcare

VIRENT BIOFORMPX PARAXYLENE USED FOR WORLD’S FIRST PET PLASTIC BOTTLE MADE ENTIRELY FROM PLANT-BASED MATERIAL

Wednesday, June 3rd, 2015 | Clean Tech

ALLIQUA BIOMEDICAL, INC. ANNOUNCES CLOSING OF CELLERATION, INC. ACQUISITION

Monday, June 1st, 2015 | Healthcare

EUTHYMICS REPORTS TOP-LINE RESULTS FROM TRIADE TRIAL OF AMITIFADINE FOR MAJOR DEPRESSIVE DISORDER

Friday, May 29th, 2015 | Healthcare

AKEBIA ANNOUNCES PRESENTATION OF PHASE 2B DATA FOR AKB-6548 IN NON-DIALYSIS PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE AT THE 52ND ERA-EDTA CONGRESS

Friday, May 29th, 2015 | Healthcare

NEUWAVE MEDICAL INC. CLOSES $25 MILLION IN NEW FINANCING

Thursday, May 28th, 2015 | Healthcare

NEUWAVE MEDICAL INC. CLOSES $25 MILLION IN NEW FINANCING

Thursday, May 28th, 2015 | Healthcare

JUVENTAS THERAPEUTICS PRESENTS NEW 12-MONTH DATA DEMONSTRATING SINGLE ADMINISTRATION OF JVS-100 IMPROVES CARDIAC AND CLINICAL STATUS IN PATIENTS WITH SEVERE ISCHEMIC HEART FAILURE ONE YEAR AFTER TREATMENT

Tuesday, May 26th, 2015 | Healthcare

TISSUE REGENERATION SYSTEMS $4.09 MILLION FUNDRAISING. WILLIAM J. FITZSIMMONS SUBMITTED MAY 18 SEC FORM

Monday, May 18th, 2015 | Healthcare

JUVENTAS THERAPEUTICS ADDS $13.5 MILLION IN NEW FINANCING AND EXPANDS BOARD OF DIRECTORS

Tuesday, May 12th, 2015 | Healthcare

HEALTHMYNE, INC. ADDS DEL COUFAL AS VP OF MARKETING AND BUSINESS DEVELOPMENT

Monday, May 11th, 2015 | Healthcare

AKEBIA THERAPEUTICS ANNOUNCES CLOSING OF PUBLIC OFFERING AND FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

Wednesday, April 22nd, 2015 | Healthcare

OXFORD FINANCE AND SILICON BANK CLOSE $12 MILLION SENIOR CREDIT FACILITY WITH RESHAPE MEDICAL

Tuesday, April 21st, 2015 | Healthcare

CHROMATIN: SORGHUM PARTNERS ANNOUNCES SUGARCANE APHID INTEGRATED PEST MANAGEMENT PROGRAM

Thursday, April 16th, 2015 | Clean Tech

CELLECTAR BIOSCIENCES INITIATES PROOF-OF-CONCEPT TRIAL OF I-131-CLR1404 IN MULTIPLE MYELOMA

Wednesday, April 15th, 2015 | Healthcare

ALFALIGHT: HIGH-POWER LASER SPINOFF PROVES VERSATILITY IS STRENGTH

Monday, April 13th, 2015 | Clean Tech

FDA SAYS RESHAPE MEDICAL CAN SKIP ADVISORY PANEL FOR OBESITY BALLOON DEVICE

Tuesday, April 7th, 2015 | Healthcare

CELLECTAR BIOSCIENCES: READY, AIM, FIRE! CANCER-TARGETING MECHANISM UNDERLIES PROMISING UW-MADISON SPINOFF

Monday, March 30th, 2015 | Healthcare

MIST THERAPY DEMONSTRATES BETTER HEALING AND REDUCED RECIDIVISM IN SPLIT THICKNESS DONOR SITE RANDOMIZED CONTROLLED TRIAL

Thursday, March 26th, 2015 | Healthcare

CHROMATIN SORGHUM HYBRIDS PRODUCE FIVEFOLD YIELD INCREASE IN EAST AFRICA

Wednesday, March 18th, 2015 | Clean Tech

AKEBIA ANNOUNCES PRESENTATION OF RESULTS FROM ITS PHASE 2B STUDY OF AKB-6548 IN NON-DIALYSIS PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE AT THE INTERNATIONAL SOCIETY OF NEPHROLOGY’S WORLD CONGRESS OF NEPHROLOGY

Monday, March 16th, 2015 | Healthcare

AKEBIA TRIAL SHOWS ANEMIA DRUG SPURS “CONTROLLED” RESPONSE

Monday, March 16th, 2015 | Healthcare

MADISON VACCINES EXPANDS INVESTIGATIONAL PROSTATE CANCER VACCINES

Thursday, March 12th, 2015 | Healthcare

MADISON VACCINES EXPANDS SERIES A TO ADVANCE PROSTATE CANCER DRUGS

Tuesday, March 10th, 2015 | Healthcare

HEALTHMYNE RAISES $4.5M IN SERIES A ROUND OF VENTURE CAPITAL FINANCING

Tuesday, March 10th, 2015 | Technology

AKEBIA ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2 TRIAL OF AKB-6548 IN DIALYSIS PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE

Tuesday, March 10th, 2015 | Healthcare

AERPIO THERAPEUTICS ANNOUNCES PUBLICATION OF POSITIVE RESULTS OF PHASE 1B/2A CLINICAL TRIAL OF NOVEL TIE2 ACTIVATOR, AKB-9778, FOR THE TREATMENT OF PATIENTS WITH DIABETIC MACULAR EDEMA (DME) – TIME-1 STUDY

Wednesday, March 4th, 2015 | Healthcare

CHROMATIN EXPANDS ITS EXECUTIVE TEAM

Thursday, February 26th, 2015 | Clean Tech

CHROMATIN, INC. ANNOUNCES PRODUCTION OF FARNESENE IN SORGHUM

Wednesday, February 25th, 2015 | Clean Tech

CHROMATIN: SORGHUM PARTNERS BRINGS MARKET LEADING HYBRIDS TO NORTH CAROLINA

Thursday, February 19th, 2015 | Clean Tech

NEUWAVE MEDICAL: EXERGEN GLOBAL’S TEMPERATURE SENSOR ENSURES SAFETY, EFFICIENCY FOR ABLATION SYSTEMS

Wednesday, February 18th, 2015 | Healthcare

CHROMATIN EXPANDING ITS PRESENCE IN THE REGION

Wednesday, February 11th, 2015 | Clean Tech

ALLIQUA BIOMEDICAL, INC. TO ACQUIRE CELLERATION, INC.

Monday, February 2nd, 2015 | Healthcare

VENTURE INVESTORS’ PORTFOLIO COMPANY, TISSUE REGENERATION SYSTEMS (TRS), COLLABORATION WITH JOHNSON & JOHNSON VIDEO

Friday, January 30th, 2015 | Healthcare

VENTURE INVESTORS: MICHIGAN VENTURE CAPITAL INVESTMENT VALUE UP NEARLY 100% FROM 2013

Wednesday, January 28th, 2015 | Venture Investors

CELLERATION, INC. ANNOUNCES STATISTICALLY SIGNIFICANT BETTER HEALING WITH MIST THERAPY IN THE IN-BALANCE VLU RANDOMIZED CONTROL TRIAL

Tuesday, January 27th, 2015 | Healthcare

ALFALIGHT RECEIVES $1.9M RAYTHEON CONTRACT TO DELIVER LASER SUBSYSTEMS FOR AEROSPACE APPLICATION

Thursday, January 22nd, 2015 | Clean Tech

COKE’S PLANT BOTTLE – COCA COLA INVESTS FURTHER IN SCALING VIRENT’S PARAXYLENE PRODUCTION

Thursday, January 22nd, 2015 | Clean Tech

PEER-REVIEWED GLIOMA SURGERY STUDY WITH CELLECTAR BIOSCIENCES FLUORESCENCE CANCER-TARGETING AGENTS CHOSEN FOR THE COVER OF NEUROSURGERY

Thursday, January 22nd, 2015 | Healthcare

UPTO INTROS PLUGIN FOR CHROME, BRINGS FEATURES TO GOOGLE CALENDAR

Thursday, January 15th, 2015 | Technology

TISSUE REGENERATION SYSTEMS ADDS BUSINESS DEVELOPMENT EXECUTIVE

Wednesday, January 14th, 2015 | Healthcare

SILATRONIX: UW GRANT PROGRAM SEEDS PROMISING IDEAS, LIKE SAFER BATTERIES

Thursday, January 8th, 2015 | Clean Tech

AKEBIA COMPLETES ENROLLMENT IN THE TWO PLANNED COHORTS OF ITS PHASE 2 STUDY OF AKB-6548 IN PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS

Monday, January 5th, 2015 | Healthcare

HISTOSONICS: UNIVERSITIES PUSH HARDER INTO REALM OF STARTUPS

Wednesday, December 17th, 2014 | Healthcare

WISCONSIN STILL MISSING AN INGREDIENT IN THE START-UP STEW

Wednesday, December 17th, 2014 | Venture Investors

AKEBIA THERAPEUTICS, INC. ADDED TO NASDAQ BIOTECHNOLOGY INDEX

Monday, December 15th, 2014 | Healthcare

NEUROVANCE ANNOUNCES TOP-LINE STUDY RESULTS SUGGEST LOWER ABUSE POTENTIAL FOR CENTANAFADINE COMPARED TO STIMULANTS USED FOR ADULT ADHD

Thursday, December 11th, 2014 | Healthcare

VIRENT ANNOUNCES WORLD’S FIRST DEMONSTRATION OF FULL RANGE BIO-AROMATICS PRODUCTION

Thursday, December 11th, 2014 | Clean Tech

AERPIO THERAPEUTICS COMPLETES ENROLLMENT OF PHASE 2 STUDY OF TIE2 ACTIVATOR AKB-9778 FOR THE TREATMENT OF PATIENTS WITH DIABETIC MACULAR EDEMA

Thursday, December 4th, 2014 | Healthcare

CELLECTAR BIOSCIENCES GRANTED ORPHAN DESIGNATION FOR I-131-CLR1404 FOR THE TREATMENT OF MULTIPLE MYELOMA

Thursday, December 4th, 2014 | Healthcare

CHROMATIN: SORGHUM PARTNERS SORGHUM HYBRIDS DEMONSTRATE TOLERANCE AGAINST SUGARCANE APHIDS

Thursday, December 4th, 2014 | Clean Tech

RESHAPE MEDICAL: A BALLOON MAY AID WEIGHT LOSS

Thursday, November 27th, 2014 | Healthcare

CELLECTAR BIOSCIENCES NAMES CAMERON SZAKACS, PH.D. VICE PRESIDENT OF CLINICAL DEVELOPMENT

Tuesday, November 25th, 2014 | Healthcare

VIRENT: SHELL EXPECTS TO BE PRODUCING ADVANCED BIOFUELS AT SCALE, IN US, BY END OF DECADE

Monday, November 24th, 2014 | Clean Tech

RESHAPE MEDICAL: A BALLOON FOR OBESITY – AN OPTION BETWEEN MEDICATION AND SURGERY?

Monday, November 24th, 2014 | Healthcare

CHROMATIN: TECHAG DEMONSTRATES EXCEPTIONAL PERFORMANCE OF SORGHUM PARTNERS HYBRID SORGHUM PRODUCTS IN MEXICO

Wednesday, November 19th, 2014 | Clean Tech

JUVENTAS THERAPEUTICS PRESENTS PHASE II DATA AT AHA SCIENTIFIC SESSIONS THAT SHOWS JVS-100 IS SAFE, POTENTIALLY EFFECTIVE IN PATIENTS WITH CRITICAL LIMB ISCHEMIA

Tuesday, November 18th, 2014 | Healthcare

CHROMATIN INC. APPOINTS TROY RANDOLPH AS CHIEF FINANCIAL OFFICER

Thursday, November 13th, 2014 | Clean Tech

RESHAPE MEDICAL UNVEILS US PIVOTAL TRIAL RESULTS FOR NON-SURGICAL WEIGHT LOSS PROCEDURE FEATURED IN TOP 10 PAPER AT OBESITY WEEK 2014

Tuesday, November 4th, 2014 | Healthcare

VIRENT: THE NEW ALCHEMY? COMPANY MAKES JET FUEL AND PLASTIC SODA BOTTLES OUT OF FARM WASTES

Tuesday, November 4th, 2014 | Clean Tech

VIRENT AND THE PLANTPET TECHNOLOGY COLLABORATIVE (PTC) SIGN EXPRESSION OF INTEREST TO ACCESS COMMERCIAL QUANTITIES OF VIRENT’S BIOFORMPX PARAXYLENE

Thursday, October 30th, 2014 | Clean Tech

CHROMATIN, INC. RECEIVES GOVERNOR’S EXPORT AWARD

Tuesday, October 28th, 2014 | Clean Tech

JUVENTAS THERAPEUTICS STRENGTHENS MANAGEMENT TEAM WITH NEW SENIOR VICE PRESIDENT OF FINANCE AND OPERATIONS

Tuesday, October 28th, 2014 | Healthcare